This kind of cytogenetic aberration is highly significant for diagnosis and therapy management, since on its own associates with favorable outcomes, high remission rates and long median survival, whereas c-Kit mutations occurring concurrently with t(8;21)(q22; q22) , compose an independent adverse prognostic biomarker ( Table 2 , Figure 2 ).
← all excerpts
Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia.
1
—
—